The stock of Tandem Diabetes Care Inc (NASDAQ:TNDM) is a huge mover today! About 1.41M shares traded hands or 208.91% up from the average. Tandem Diabetes Care Inc (NASDAQ:TNDM) has declined 76.83% since April 18, 2016 and is downtrending. It has underperformed by 81.26% the S&P500.
The move comes after 5 months positive chart setup for the $99.59M company. It was reported on Nov, 18 by Barchart.com. We have $4.99 PT which if reached, will make NASDAQ:TNDM worth $91.62M more.
Tandem Diabetes Care Inc (NASDAQ:TNDM) Ratings Coverage
Out of 9 analysts covering Tandem Diabetes Care (NASDAQ:TNDM), 3 rate it a “Buy”, 1 “Sell”, while 5 “Hold”. This means 33% are positive. Tandem Diabetes Care has been the topic of 17 analyst reports since August 5, 2015 according to StockzIntelligence Inc. Piper Jaffray downgraded the shares of TNDM in a report on Thursday, November 3 to “Neutral” rating. Feltl & Co downgraded the stock to “Buy” rating in Wednesday, November 2 report. Deutsche Bank maintained Tandem Diabetes Care Inc (NASDAQ:TNDM) on Monday, August 10 with “Buy” rating. As per Thursday, August 20, the company rating was downgraded by Zacks. The firm has “Underperform” rating given on Thursday, March 24 by Bank of America. PiperJaffray downgraded the stock to “Neutral” rating in Thursday, November 3 report. The stock of Tandem Diabetes Care Inc (NASDAQ:TNDM) earned “Buy” rating by Deutsche Bank on Wednesday, November 2. Robert W. Baird downgraded Tandem Diabetes Care Inc (NASDAQ:TNDM) on Wednesday, November 2 to “Neutral” rating. As per Wednesday, August 5, the company rating was upgraded by Zacks. The firm earned “Hold” rating on Friday, September 4 by Zacks.
According to Zacks Investment Research, “Tandem Diabetes Care, Inc. is a medical device company. The Company designs, develops, and commercializes products for people with insulin-dependent diabetes. Its products include t:slim Insulin Delivery System. Tandem Diabetes Care, Inc. is headquartered in San Diego, California.”
Insitutional Activity: The institutional sentiment increased to 1.32 in Q2 2016. Its up 0.30, from 1.02 in 2016Q1. The ratio increased, as 18 funds sold all Tandem Diabetes Care Inc shares owned while 24 reduced positions. 9 funds bought stakes while 34 increased positions. They now own 17.85 million shares or 6.33% less from 19.06 million shares in 2016Q1.
Stonebridge Capital, a California-based fund reported 10,405 shares. Eventide Asset Ltd owns 275,000 shares or 0.13% of their US portfolio. Moreover, Rhumbline Advisers has 0% invested in Tandem Diabetes Care Inc (NASDAQ:TNDM) for 16,317 shares. Blackrock Investment Management Ltd accumulated 67,977 shares or 0% of the stock. Bluestein R H &, a Michigan-based fund reported 10,625 shares. Keybank Natl Association Oh last reported 34,765 shares in the company. Dowling And Yahnke Llc reported 17,572 shares or 0.02% of all its holdings. Frontier Cap Ltd Company reported 1.12 million shares or 0.07% of all its holdings. Moreover, Morgan Stanley has 0% invested in Tandem Diabetes Care Inc (NASDAQ:TNDM) for 719 shares. The Maryland-based Rock Springs Capital Mgmt L P has invested 0.33% in Tandem Diabetes Care Inc (NASDAQ:TNDM). Geode Mngmt Lc accumulated 0% or 143,685 shares. Royal National Bank & Trust Of Canada last reported 4,164 shares in the company. Envestnet Asset Mngmt owns 1,649 shares or 0% of their US portfolio. Blackrock Fund Advsrs accumulated 0% or 477,327 shares. Renaissance Technologies Ltd Liability Corp has 294,300 shares for 0% of their US portfolio.
More important recent Tandem Diabetes Care Inc (NASDAQ:TNDM) news were published by: Businesswire.com which released: “NIH-funded International Diabetes Closed Loop (IDCL) Trial to Combine …” on November 10, 2016, also Fool.com published article titled: “Why Insulet Corporation and Tandem Diabetes Care Both Tanked Today”, Businesswire.com published: “Tandem Diabetes Care Reports Third Quarter 2016 Financial Results” on November 01, 2016. More interesting news about Tandem Diabetes Care Inc (NASDAQ:TNDM) was released by: Businesswire.com and their article: “Tandem Diabetes Care Now Shipping Next-Generation t:slim X2 Insulin Pump” with publication date: October 24, 2016.
TNDM Company Profile
Tandem Diabetes Care, Inc., incorporated on January 7, 2008, is a medical device company. The Firm is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Firm makes and sells over three insulin pump products in the United States that are designed to address insulin-dependent diabetes market, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). The Company’s technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump’s cartridge rather than relying on a syringe and plunger mechanism. The Firm also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud data management application that provides display therapy management data from the pump and supported blood glucose meters.